Tsujino S#, Deguchi S#, Nomai T#, Padilla-Blanco M#, Plianchaisuk A#, Wang L#, Begum MM#, Uriu K# (#equal contribution), Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima Hi, Sasaki-Tabata K, Guo Z, Hinay Jr. AA, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T*, Takayama K*, Zahradnik J*, Hashiguchi T*, Fukuhara T*, Sato K* (*equal correspondence). Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant. Microbiol Immunol. 2024. [link].